Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00529555 · ClinicalTrials.gov registry record · Phase 3
Periocline as an Adjunct to Scaling and Root Planing for Adult Periodontitis
A Phase 3 study, sponsored by Sunstar Americas.
- Completed
- Registry status
- Phase 3
- Development phase
- 602
- Enrollment target
NCT00529555: Completed Phase 3 study, sponsored by Sunstar Americas.
NCT00529555 is a Phase 3 study that has completed, run by Sunstar Americas. The registered enrollment target is 602 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (22% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00529555, a Phase 3 study, has completed, sponsored by Sunstar Americas.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 602 participants
- Enrollment target
Study Summary
Periodontal disease (commonly called gum disease) is generally treated by deep cleaning of the root surfaces of the teeth. This is also called scaling and root planing. Placing a topical antibiotic into the periodontal pocket at the time of scaling and root planing may help reduce pocket depth and thus help the periodontal disease. Periocline (minocycline HCl) 2.1% gel is a topical antibiotic approved in a number of countries for this use, and is now being tested in the US.
Primary Outcome
Average change of Pocket Depth at 9 months from baseline
Interventions
- PROCEDURE Scaling and root planing
- DRUG minocycline HCl 2.1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 602 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
What the finished NCT00529555 record still lists
NCT00529555 is an interventional study that assigns participants to a tested intervention. The registered 602 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (22% lower).
The record links to 0 conditions, and to 2 interventions - of which Scaling and root planing is the first listed.
NCT00529555 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00529555 about?
NCT00529555 is a clinical study titled "Periocline as an Adjunct to Scaling and Root Planing for Adult Periodontitis". Periodontal disease (commonly called gum disease) is generally treated by deep cleaning of the root surfaces of the teeth. This is also called scaling and root planing. Placing a topical antibiotic into the periodontal pocket at the time of scaling and root planing may help reduce pocket depth and t...
What is the current status of trial NCT00529555?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 602 participants. The study started on 2006-01. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00529555?
The interventions under investigation include: Scaling and root planing (PROCEDURE), minocycline HCl 2.1% (DRUG).
Who is sponsoring clinical trial NCT00529555?
This trial is sponsored by Sunstar Americas, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00529555's enrollment target sits among peer trials
602 607th of 2000 higher than 1,393 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03849443 · 604 participants · Early Phase 1
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
- NCT05238922 · 604 participants · Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- NCT06040541 · 604 participants · Phase 1
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia